Liyan Xu

47PUBLICATIONS
130CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Apr 13, 2026
IL1RAP Antibody-Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers.

Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang

|Nov 22, 2025
Integrating multi-omics to reveal the molecular mechanism of lipid metabolism regulated by a splice variant of Lysyl-oxidase like-2, LOXL2Δ13.

Yang Chen, Liu Peng, Jian-Zhong He

|Oct 07, 2025
Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer.

Wen-Zhi Wu, He-Cheng Huang, Guang-Hui Zhu

|Sep 02, 2025
SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape.

Zhen Wang, Ruofei Dai, Li Kang

|Aug 11, 2025
Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.

Lin-Ting Zhang, Xin-Yi Wu, Hai-Yu Zhang

|Mar 02, 2025
Chromatin assembly factor 1 subunit A promotes TLS pathway by recruiting E3 ubiquitin ligase RAD18 in cancer cells.

Bing Wen, Hai-Xiang Zheng, Jing-Hua Heng

Pageof 8

Frequent Collaborators

34 joint publications

Enmin Li

4 joint publications

Jiemin Wong

3 joint publications

Lin Long

3 joint publications

Benjamin P Berman